Hospital volume and prognosis of patients with metastatic pancreatic cancer: A study using the Osaka Cancer Registry

Purpose Pancreatic cancer (PC) has one of the worst prognoses among all solid cancers. Hospital volume has been shown to be significantly associated with outcomes in patients with PC undergoing surgery. Nonetheless, the association between hospital volume and prognosis in patients with metastatic PC...

Full description

Saved in:
Bibliographic Details
Published in:Journal of cancer research and clinical oncology 2023-11, Vol.149 (14), p.12835-12841
Main Authors: Kawamoto, Yasuharu, Ikezawa, Kenji, Tabuchi, Takahiro, Morishima, Toshitaka, Seiki, Yusuke, Watsuji, Ko, Hirao, Takeru, Higashi, Sena, Urabe, Makiko, Kai, Yugo, Takada, Ryoji, Yamai, Takuo, Mukai, Kaori, Nakabori, Tasuku, Uehara, Hiroyuki, Miyashiro, Isao, Ohkawa, Kazuyoshi
Format: Article
Language:English
Subjects:
Cancer Research
Chemotherapy
Hematology
Hospitals
Internal Medicine
Medical prognosis
Medicine
Medicine & Public Health
Metastases
Metastasis
Multivariate analysis
Oncology
Pancreatic cancer
Patients
Prognosis
Radiation therapy
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Purpose Pancreatic cancer (PC) has one of the worst prognoses among all solid cancers. Hospital volume has been shown to be significantly associated with outcomes in patients with PC undergoing surgery. Nonetheless, the association between hospital volume and prognosis in patients with metastatic PC remains unclear. This study aimed to examine the association between hospital volume and prognosis in patients with metastatic PC using large-scale population-based cancer registry data. Methods This retrospective observational study was conducted using data from the Osaka Cancer Registry database. Data of patients with metastatic PC over 10 years (2009–2018) were obtained. Hospitals were categorized into high-volume hospitals (HVHs; ≥ 240 patients diagnosed with PC for 10 years), middle-volume hospitals (MVHs; 120–239 patients diagnosed with PC for 10 years), and low-volume hospitals (LVHs; 
ISSN:0171-5216
1432-1335
DOI:10.1007/s00432-023-04966-x